FDA Sublingual Lesson Surfaces Again In Dietary Supplement Warning
This article was originally published in The Rose Sheet
Executive Summary
The latest firm to hear from FDA that sublingual tablets are not supplements is Bio-Stasis International, according to a warning letter from the Office of Regulatory Affairs' Los Angeles District.
You may also be interested in...
Spray Supplement Zinc Up Developed On Idea Of Providing Immunity ‘Barrier’ For First Responders
"We were seeing how important immune support is and that’s kind of the origination of the idea," says Nutritional Brands CEO Danna Pratte. "It really was sparked because of the conversation about first responders and their need for protection."
FDA Liquid Supplement/Beverage Guidance Defines Distinctions
The CFSAN guidance goes into greater detail on distinguishing liquid supplements from beverages, addressing stakeholders’ complaint about a 2009 draft. “This tends to really draw a bright line between the two different categories,” says CRN Regulatory Counsel Rend Al-Mondhiry.
In Brief: warning letters, UrgentRx OTCs fly, Innovus acquires Semprae
GMPs apply despite product discontinuation; format renders spray products drugs; Rogaine label clarified; UrgentRx OTCs take flight; Innovus acquires Semprae; Omega Protein closes plant; FDA evaluates consumer communication; and EU vitamin, mineral, botanical sales outpace forecast.